Funding for this research was provided by:
Sociedad Española de Oncología Médica
Text and Data Mining valid from 2019-04-15
Received: 18 December 2018
Accepted: 22 March 2019
First Online: 15 April 2019
Ethics approval and consent to participate
: Human samples were obtained from clinical trial and biobanking protocols which have been approved by the UK National Ethics Committee (Prospect C trial approval number: 12/LO/0914, Prospect R trial approval number: 14/LO/1812, FOrMAT trial approval number 13/LO/1274, Improving Outcomes in Cancer biobanking protocol approval number: 13/EM/0327, approval number for use of buffy coats from the blood bank: 06/Q1206/106). All individuals provided written informed consent for sample donation and use for research.
: All authors read the manuscript and consented to publication.
: Dr. Gonzalez-Exposito was supported by a fellowship grant from the Spanish Society of Medical Oncology for Translational Research in Reference Centers that was funded by Roche (FSEOM/Roche). Dr. Gerlinger receives research funding from Merck KG.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.